(Q86825600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

8

Roger E McLendon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

3

Annick Desjardins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

David A Reardon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

James J Vredenburgh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Jennifer A Quinn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Alan D Austin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

James E Herndon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Henry S Friedman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

18 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

135-140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686298%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-013-1162-y

1 March 2020

exact match

0 references

cites work

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

1 reference

12 December 2020

1 reference

12 December 2020

Complete response to temozolomide treatment in an elderly patient with recurrent primary central nervous system lymphoma--case report

1 reference

12 December 2020

Loss of O6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphoma

1 reference

12 December 2020

Temozolomide as salvage treatment in primary brain lymphomas.

1 reference

12 December 2020

An update on therapy of primary central nervous system lymphoma

1 reference

12 December 2020

Potential of chemo-immunotherapy and radioimmunotherapy in relapsed primary central nervous system (CNS) lymphoma

1 reference

12 December 2020

Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study

1 reference

12 December 2020

Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas

1 reference

12 December 2020

First-line therapy with temozolomide induces regression of primary CNS lymphoma.

1 reference

12 December 2020

Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide

1 reference

12 December 2020

Primary central nervous system lymphoma

1 reference

12 December 2020

Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status

1 reference

12 December 2020

Immunohistochemical detection of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in formalin-fixed, paraffin-embedded astrocytomas.

1 reference

12 December 2020

Case report: a patient with primary CNS lymphoma treated with temozolomide to complete response

1 reference

12 December 2020

Decreasing incidence rates of primary central nervous system lymphoma

1 reference

12 December 2020

Patterns of treatment in older adults with primary central nervous system lymphoma

1 reference

12 December 2020

Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.

1 reference

12 December 2020

Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status

1 reference

12 December 2020

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of

1 reference

12 December 2020

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial.

1 reference

12 December 2020

O⁶-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment.

1 reference

12 December 2020

Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly

1 reference

12 December 2020

1 reference

12 December 2020

Cognitive status and quality of life after treatment for primary CNS lymphoma

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

Understanding and managing methotrexate nephrotoxicity

1 reference

12 December 2020

MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression

1 reference

12 December 2020

Temozolomide: a milestone in neuro-oncology and beyond?

1 reference

12 December 2020

Treatment-related neurotoxicity

1 reference

12 December 2020

Epigenetic silencing of multiple genes in primary CNS lymphoma

1 reference

12 December 2020

Primary central nervous system lymphoma: biological aspects and controversies in management

1 reference

12 December 2020

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

1 reference

12 December 2020